CAPR
Capricor TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CAPR vs peer average
57/100
CAPR vs. peer average (C vs. C)
Grade spread
B 3 · C 2 · D 4 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
INBX is the first available peer comparator.
Small-cap biotech peer with similar financing sensitivity and single-asset execution risk, though not a Duchenne-focused comp.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CAPR
Capricor Therapeutics
INBX
Inhibrx Biosciences
Grade
C
F
Momentum
5
26
Value
41
41
Sentiment
100
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs INBX
CAPR / INBX
Grade Position
In line
CAPR vs. peer average (C vs. C)
57/100
Momentum
5
INBXValue
41
CAPRSentiment
100
CAPRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CAPR
INBX is the first peer returned for this comparison set.